Request for Covid-19 Impact Assessment of this Report
The United States Ophthalmic Medicine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ophthalmic Medicine market, reaching US$ million by the year 2028. As for the Europe Ophthalmic Medicine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Ophthalmic Medicine players cover Novaliq, Shenyang Xingqi Pharmaceutical Co.,Ltd., Zhejiang Shapuaisi Pharmaceutical, and Chengdu Kanghong Pharmaceutical Group, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmic Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Eye Drops
Eye Ointment
Gelling Agent
Tablet
Injection
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Anti-fatigue and Dryness
Cataract
Anti-infective
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novaliq
Shenyang Xingqi Pharmaceutical Co.,Ltd.
Zhejiang Shapuaisi Pharmaceutical
Chengdu Kanghong Pharmaceutical Group
Santen Pharmaceutica
Bausch Health
Alcon NV
Mentholatum
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ophthalmic Medicine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Ophthalmic Medicine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Ophthalmic Medicine by Country/Region, 2017, 2022 & 2028
2.2 Ophthalmic Medicine Segment by Type
2.2.1 Eye Drops
2.2.2 Eye Ointment
2.2.3 Gelling Agent
2.2.4 Tablet
2.2.5 Injection
2.3 Ophthalmic Medicine Sales by Type
2.3.1 Global Ophthalmic Medicine Sales Market Share by Type (2017-2022)
2.3.2 Global Ophthalmic Medicine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Ophthalmic Medicine Sale Price by Type (2017-2022)
2.4 Ophthalmic Medicine Segment by Application
2.4.1 Anti-fatigue and Dryness
2.4.2 Cataract
2.4.3 Anti-infective
2.5 Ophthalmic Medicine Sales by Application
2.5.1 Global Ophthalmic Medicine Sale Market Share by Application (2017-2022)
2.5.2 Global Ophthalmic Medicine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Ophthalmic Medicine Sale Price by Application (2017-2022)
3 Global Ophthalmic Medicine by Company
3.1 Global Ophthalmic Medicine Breakdown Data by Company
3.1.1 Global Ophthalmic Medicine Annual Sales by Company (2020-2022)
3.1.2 Global Ophthalmic Medicine Sales Market Share by Company (2020-2022)
3.2 Global Ophthalmic Medicine Annual Revenue by Company (2020-2022)
3.2.1 Global Ophthalmic Medicine Revenue by Company (2020-2022)
3.2.2 Global Ophthalmic Medicine Revenue Market Share by Company (2020-2022)
3.3 Global Ophthalmic Medicine Sale Price by Company
3.4 Key Manufacturers Ophthalmic Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ophthalmic Medicine Product Location Distribution
3.4.2 Players Ophthalmic Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Ophthalmic Medicine by Geographic Region
4.1 World Historic Ophthalmic Medicine Market Size by Geographic Region (2017-2022)
4.1.1 Global Ophthalmic Medicine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Ophthalmic Medicine Annual Revenue by Geographic Region
4.2 World Historic Ophthalmic Medicine Market Size by Country/Region (2017-2022)
4.2.1 Global Ophthalmic Medicine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Ophthalmic Medicine Annual Revenue by Country/Region
4.3 Americas Ophthalmic Medicine Sales Growth
4.4 APAC Ophthalmic Medicine Sales Growth
4.5 Europe Ophthalmic Medicine Sales Growth
4.6 Middle East & Africa Ophthalmic Medicine Sales Growth
5 Americas
5.1 Americas Ophthalmic Medicine Sales by Country
5.1.1 Americas Ophthalmic Medicine Sales by Country (2017-2022)
5.1.2 Americas Ophthalmic Medicine Revenue by Country (2017-2022)
5.2 Americas Ophthalmic Medicine Sales by Type
5.3 Americas Ophthalmic Medicine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmic Medicine Sales by Region
6.1.1 APAC Ophthalmic Medicine Sales by Region (2017-2022)
6.1.2 APAC Ophthalmic Medicine Revenue by Region (2017-2022)
6.2 APAC Ophthalmic Medicine Sales by Type
6.3 APAC Ophthalmic Medicine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ophthalmic Medicine by Country
7.1.1 Europe Ophthalmic Medicine Sales by Country (2017-2022)
7.1.2 Europe Ophthalmic Medicine Revenue by Country (2017-2022)
7.2 Europe Ophthalmic Medicine Sales by Type
7.3 Europe Ophthalmic Medicine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ophthalmic Medicine by Country
8.1.1 Middle East & Africa Ophthalmic Medicine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Ophthalmic Medicine Revenue by Country (2017-2022)
8.2 Middle East & Africa Ophthalmic Medicine Sales by Type
8.3 Middle East & Africa Ophthalmic Medicine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ophthalmic Medicine
10.3 Manufacturing Process Analysis of Ophthalmic Medicine
10.4 Industry Chain Structure of Ophthalmic Medicine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ophthalmic Medicine Distributors
11.3 Ophthalmic Medicine Customer
12 World Forecast Review for Ophthalmic Medicine by Geographic Region
12.1 Global Ophthalmic Medicine Market Size Forecast by Region
12.1.1 Global Ophthalmic Medicine Forecast by Region (2023-2028)
12.1.2 Global Ophthalmic Medicine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ophthalmic Medicine Forecast by Type
12.7 Global Ophthalmic Medicine Forecast by Application
13 Key Players Analysis
13.1 Novaliq
13.1.1 Novaliq Company Information
13.1.2 Novaliq Ophthalmic Medicine Product Offered
13.1.3 Novaliq Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novaliq Main Business Overview
13.1.5 Novaliq Latest Developments
13.2 Shenyang Xingqi Pharmaceutical Co.,Ltd.
13.2.1 Shenyang Xingqi Pharmaceutical Co.,Ltd. Company Information
13.2.2 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product Offered
13.2.3 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Shenyang Xingqi Pharmaceutical Co.,Ltd. Main Business Overview
13.2.5 Shenyang Xingqi Pharmaceutical Co.,Ltd. Latest Developments
13.3 Zhejiang Shapuaisi Pharmaceutical
13.3.1 Zhejiang Shapuaisi Pharmaceutical Company Information
13.3.2 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product Offered
13.3.3 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Zhejiang Shapuaisi Pharmaceutical Main Business Overview
13.3.5 Zhejiang Shapuaisi Pharmaceutical Latest Developments
13.4 Chengdu Kanghong Pharmaceutical Group
13.4.1 Chengdu Kanghong Pharmaceutical Group Company Information
13.4.2 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product Offered
13.4.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Chengdu Kanghong Pharmaceutical Group Main Business Overview
13.4.5 Chengdu Kanghong Pharmaceutical Group Latest Developments
13.5 Santen Pharmaceutica
13.5.1 Santen Pharmaceutica Company Information
13.5.2 Santen Pharmaceutica Ophthalmic Medicine Product Offered
13.5.3 Santen Pharmaceutica Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Santen Pharmaceutica Main Business Overview
13.5.5 Santen Pharmaceutica Latest Developments
13.6 Bausch Health
13.6.1 Bausch Health Company Information
13.6.2 Bausch Health Ophthalmic Medicine Product Offered
13.6.3 Bausch Health Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Bausch Health Main Business Overview
13.6.5 Bausch Health Latest Developments
13.7 Alcon NV
13.7.1 Alcon NV Company Information
13.7.2 Alcon NV Ophthalmic Medicine Product Offered
13.7.3 Alcon NV Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Alcon NV Main Business Overview
13.7.5 Alcon NV Latest Developments
13.8 Mentholatum
13.8.1 Mentholatum Company Information
13.8.2 Mentholatum Ophthalmic Medicine Product Offered
13.8.3 Mentholatum Ophthalmic Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Mentholatum Main Business Overview
13.8.5 Mentholatum Latest Developments
14 Research Findings and Conclusion
Table 1. Ophthalmic Medicine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Ophthalmic Medicine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Eye Drops
Table 4. Major Players of Eye Ointment
Table 5. Major Players of Gelling Agent
Table 6. Major Players of Tablet
Table 7. Major Players of Injection
Table 8. Global Ophthalmic Medicine Sales by Type (2017-2022) & (K Units)
Table 9. Global Ophthalmic Medicine Sales Market Share by Type (2017-2022)
Table 10. Global Ophthalmic Medicine Revenue by Type (2017-2022) & ($ million)
Table 11. Global Ophthalmic Medicine Revenue Market Share by Type (2017-2022)
Table 12. Global Ophthalmic Medicine Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global Ophthalmic Medicine Sales by Application (2017-2022) & (K Units)
Table 14. Global Ophthalmic Medicine Sales Market Share by Application (2017-2022)
Table 15. Global Ophthalmic Medicine Revenue by Application (2017-2022)
Table 16. Global Ophthalmic Medicine Revenue Market Share by Application (2017-2022)
Table 17. Global Ophthalmic Medicine Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global Ophthalmic Medicine Sales by Company (2020-2022) & (K Units)
Table 19. Global Ophthalmic Medicine Sales Market Share by Company (2020-2022)
Table 20. Global Ophthalmic Medicine Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Ophthalmic Medicine Revenue Market Share by Company (2020-2022)
Table 22. Global Ophthalmic Medicine Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers Ophthalmic Medicine Producing Area Distribution and Sales Area
Table 24. Players Ophthalmic Medicine Products Offered
Table 25. Ophthalmic Medicine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Ophthalmic Medicine Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Ophthalmic Medicine Sales Market Share Geographic Region (2017-2022)
Table 30. Global Ophthalmic Medicine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Ophthalmic Medicine Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Ophthalmic Medicine Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Ophthalmic Medicine Sales Market Share by Country/Region (2017-2022)
Table 34. Global Ophthalmic Medicine Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Ophthalmic Medicine Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Ophthalmic Medicine Sales by Country (2017-2022) & (K Units)
Table 37. Americas Ophthalmic Medicine Sales Market Share by Country (2017-2022)
Table 38. Americas Ophthalmic Medicine Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Ophthalmic Medicine Revenue Market Share by Country (2017-2022)
Table 40. Americas Ophthalmic Medicine Sales by Type (2017-2022) & (K Units)
Table 41. Americas Ophthalmic Medicine Sales Market Share by Type (2017-2022)
Table 42. Americas Ophthalmic Medicine Sales by Application (2017-2022) & (K Units)
Table 43. Americas Ophthalmic Medicine Sales Market Share by Application (2017-2022)
Table 44. APAC Ophthalmic Medicine Sales by Region (2017-2022) & (K Units)
Table 45. APAC Ophthalmic Medicine Sales Market Share by Region (2017-2022)
Table 46. APAC Ophthalmic Medicine Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Ophthalmic Medicine Revenue Market Share by Region (2017-2022)
Table 48. APAC Ophthalmic Medicine Sales by Type (2017-2022) & (K Units)
Table 49. APAC Ophthalmic Medicine Sales Market Share by Type (2017-2022)
Table 50. APAC Ophthalmic Medicine Sales by Application (2017-2022) & (K Units)
Table 51. APAC Ophthalmic Medicine Sales Market Share by Application (2017-2022)
Table 52. Europe Ophthalmic Medicine Sales by Country (2017-2022) & (K Units)
Table 53. Europe Ophthalmic Medicine Sales Market Share by Country (2017-2022)
Table 54. Europe Ophthalmic Medicine Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Ophthalmic Medicine Revenue Market Share by Country (2017-2022)
Table 56. Europe Ophthalmic Medicine Sales by Type (2017-2022) & (K Units)
Table 57. Europe Ophthalmic Medicine Sales Market Share by Type (2017-2022)
Table 58. Europe Ophthalmic Medicine Sales by Application (2017-2022) & (K Units)
Table 59. Europe Ophthalmic Medicine Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Ophthalmic Medicine Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Ophthalmic Medicine Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Ophthalmic Medicine Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Ophthalmic Medicine Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Ophthalmic Medicine Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Ophthalmic Medicine Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Ophthalmic Medicine Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Ophthalmic Medicine Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Ophthalmic Medicine
Table 69. Key Market Challenges & Risks of Ophthalmic Medicine
Table 70. Key Industry Trends of Ophthalmic Medicine
Table 71. Ophthalmic Medicine Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Ophthalmic Medicine Distributors List
Table 74. Ophthalmic Medicine Customer List
Table 75. Global Ophthalmic Medicine Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Ophthalmic Medicine Sales Market Forecast by Region
Table 77. Global Ophthalmic Medicine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Ophthalmic Medicine Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Ophthalmic Medicine Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Ophthalmic Medicine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Ophthalmic Medicine Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Ophthalmic Medicine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Ophthalmic Medicine Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Ophthalmic Medicine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Ophthalmic Medicine Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Ophthalmic Medicine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Ophthalmic Medicine Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Ophthalmic Medicine Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Ophthalmic Medicine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Ophthalmic Medicine Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Ophthalmic Medicine Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Ophthalmic Medicine Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Ophthalmic Medicine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Ophthalmic Medicine Revenue Market Share Forecast by Application (2023-2028)
Table 95. Novaliq Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 96. Novaliq Ophthalmic Medicine Product Offered
Table 97. Novaliq Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. Novaliq Main Business
Table 99. Novaliq Latest Developments
Table 100. Shenyang Xingqi Pharmaceutical Co.,Ltd. Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 101. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product Offered
Table 102. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. Shenyang Xingqi Pharmaceutical Co.,Ltd. Main Business
Table 104. Shenyang Xingqi Pharmaceutical Co.,Ltd. Latest Developments
Table 105. Zhejiang Shapuaisi Pharmaceutical Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 106. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product Offered
Table 107. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. Zhejiang Shapuaisi Pharmaceutical Main Business
Table 109. Zhejiang Shapuaisi Pharmaceutical Latest Developments
Table 110. Chengdu Kanghong Pharmaceutical Group Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 111. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product Offered
Table 112. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. Chengdu Kanghong Pharmaceutical Group Main Business
Table 114. Chengdu Kanghong Pharmaceutical Group Latest Developments
Table 115. Santen Pharmaceutica Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 116. Santen Pharmaceutica Ophthalmic Medicine Product Offered
Table 117. Santen Pharmaceutica Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. Santen Pharmaceutica Main Business
Table 119. Santen Pharmaceutica Latest Developments
Table 120. Bausch Health Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 121. Bausch Health Ophthalmic Medicine Product Offered
Table 122. Bausch Health Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. Bausch Health Main Business
Table 124. Bausch Health Latest Developments
Table 125. Alcon NV Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 126. Alcon NV Ophthalmic Medicine Product Offered
Table 127. Alcon NV Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. Alcon NV Main Business
Table 129. Alcon NV Latest Developments
Table 130. Mentholatum Basic Information, Ophthalmic Medicine Manufacturing Base, Sales Area and Its Competitors
Table 131. Mentholatum Ophthalmic Medicine Product Offered
Table 132. Mentholatum Ophthalmic Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. Mentholatum Main Business
Table 134. Mentholatum Latest Developments
List of Figures
Figure 1. Picture of Ophthalmic Medicine
Figure 2. Ophthalmic Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ophthalmic Medicine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Ophthalmic Medicine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Ophthalmic Medicine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Eye Drops
Figure 10. Product Picture of Eye Ointment
Figure 11. Product Picture of Gelling Agent
Figure 12. Product Picture of Tablet
Figure 13. Product Picture of Injection
Figure 14. Global Ophthalmic Medicine Sales Market Share by Type in 2021
Figure 15. Global Ophthalmic Medicine Revenue Market Share by Type (2017-2022)
Figure 16. Ophthalmic Medicine Consumed in Anti-fatigue and Dryness
Figure 17. Global Ophthalmic Medicine Market: Anti-fatigue and Dryness (2017-2022) & (K Units)
Figure 18. Ophthalmic Medicine Consumed in Cataract
Figure 19. Global Ophthalmic Medicine Market: Cataract (2017-2022) & (K Units)
Figure 20. Ophthalmic Medicine Consumed in Anti-infective
Figure 21. Global Ophthalmic Medicine Market: Anti-infective (2017-2022) & (K Units)
Figure 22. Global Ophthalmic Medicine Sales Market Share by Application (2017-2022)
Figure 23. Global Ophthalmic Medicine Revenue Market Share by Application in 2021
Figure 24. Ophthalmic Medicine Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Ophthalmic Medicine Revenue Market Share by Company in 2021
Figure 26. Global Ophthalmic Medicine Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Ophthalmic Medicine Revenue Market Share by Geographic Region in 2021
Figure 28. Global Ophthalmic Medicine Sales Market Share by Region (2017-2022)
Figure 29. Global Ophthalmic Medicine Revenue Market Share by Country/Region in 2021
Figure 30. Americas Ophthalmic Medicine Sales 2017-2022 (K Units)
Figure 31. Americas Ophthalmic Medicine Revenue 2017-2022 ($ Millions)
Figure 32. APAC Ophthalmic Medicine Sales 2017-2022 (K Units)
Figure 33. APAC Ophthalmic Medicine Revenue 2017-2022 ($ Millions)
Figure 34. Europe Ophthalmic Medicine Sales 2017-2022 (K Units)
Figure 35. Europe Ophthalmic Medicine Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Ophthalmic Medicine Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Ophthalmic Medicine Revenue 2017-2022 ($ Millions)
Figure 38. Americas Ophthalmic Medicine Sales Market Share by Country in 2021
Figure 39. Americas Ophthalmic Medicine Revenue Market Share by Country in 2021
Figure 40. United States Ophthalmic Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Ophthalmic Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Ophthalmic Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Ophthalmic Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Ophthalmic Medicine Sales Market Share by Region in 2021
Figure 45. APAC Ophthalmic Medicine Revenue Market Share by Regions in 2021
Figure 46. China Ophthalmic Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Ophthalmic Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Ophthalmic Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Ophthalmic Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Ophthalmic Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Ophthalmic Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Ophthalmic Medicine Sales Market Share by Country in 2021
Figure 53. Europe Ophthalmic Medicine Revenue Market Share by Country in 2021
Figure 54. Germany Ophthalmic Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Ophthalmic Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Ophthalmic Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Ophthalmic Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Ophthalmic Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Ophthalmic Medicine Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Ophthalmic Medicine Revenue Market Share by Country in 2021
Figure 61. Egypt Ophthalmic Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Ophthalmic Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Ophthalmic Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Ophthalmic Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Ophthalmic Medicine Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Ophthalmic Medicine in 2021
Figure 67. Manufacturing Process Analysis of Ophthalmic Medicine
Figure 68. Industry Chain Structure of Ophthalmic Medicine
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...